Pro12Ala substitution in the peroxisome proliferator-activated receptor- γ2 is not associated with type 2 diabetes

Diabetes

Volumn 48, Issue 7, 1999, Pages 1466-1468

  Mancini, Francesco P ^a   Vaccaro, Olga ^a   Sabatino, Lina ^a   Tufano, Antonella ^a   Rivellese, Angela A ^a   Riccardi, Gabriele ^a   Colantuoni, Vittorio ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ADULT; AGED; ALANINE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POINT MUTATION; PROLINE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0033060302     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1466     Document Type: Article

References (20)

1. Lemberger T, Desvergne B, Wahli W: Peroxisome proliferator-activated receptors a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:335-363, 1996
2. Brun RP, Kim JB, Hu E, Spiegelman BM: Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr Opin Lipidol 8: 212-218, 1997
3. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166, 1997
4. Flier JS, Lowell BB: Obesity research springs a proton leak. Nature Genet 15:223-224, 1997
5. Spiegelman BM: PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
6. Zhu Y, Qi C, Korenberg JR, Chen X-N, Noya D, Rao MS, Reddy JK: Structural organization of the mouse peroxisome proliferator-activated receptor gamma (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci U S A 92:7921-7925, 1995
7. Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem Biophys Res Commun 224:431-437, 1996
8. De Vos P, Lefebvre A-M, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009, 1996
9. Saltiel A, Olefsky J: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
10. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39: 665-668, 1996
11. Yen C-J, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARgamma) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun 241:270-274, 1997
12. Vigouroux C, Fajas L, Khallouf E, Meier M, Gyapay G, Lascols O, Auwerx J, Weissenbach J, Capeau J, Magré J: Human peroxisome proliferator-activated receptor-γ2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 47:490-492, 1998
13. Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, Flier JS: Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ: differential activity of PPARγ1 and -2 isoforms and influence of insulin. J Biol Chem 272:20230-20235, 1997
14. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genet 20:284-287, 1998
15. Beamer BA, Yen C-J, Andersen RE, Muller D, Elahi D, Cheskin LJ, Andres R, Roth J, Shuldiner AR: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808, 1998
16. Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer BA, Shuldiner AR, Akanuma Y, Yazaki Y, Kadowaki T: Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 251:195-198, 1998
17. El-Deriny S, Ng RH, Statland BE: Evaluation of the Kodak Ektachem DT-60 analyzer. Clin Chem 32:415-419, 1986
18. Roth J, Gorden P: Clinical application of the insulin assay. In Methods in Investigative and Diagnostic Endocrinology. Berson SA, Yalow RS, Eds. Amsterdam, North Holland, 1973, p. 876-882
19. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
20. Schlesselman JJ: Case-Control Studies: Design, Conduct, Analysis. New York, Oxford University Press, 1982